What is Cardiomyopathies Matter?
Cardiomyopathies Matter is a multi-stakeholder initiative funded by Bristol Myers Squibb and Philips that aims to raise awareness of cardiomyopathies among policy-makers and to ensure these health conditions are given the policy attention they warrant both at national and EU levels.

A shared space for
stakeholders
Our latest articles
CMatter Policy Recommendations for the 2024-2029 EU Mandate
In the context of the beginning of the new EU…
CMatter Policy Recommendations for the 2024-2029 EU Mandate
New Infographic: Why EU Cardiovascular Policies Must Tackle Cardiomyopathies We…
Cardiomyopathies Matter 2024 Summit urges more policy action
On 12 November, the Cardiomyopathies Matter 2024 Summit took place,…

